MedTrace Logo

Gastroesophageal Reflux Disease in Azerbaijan

NCT03616119 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-12-13

No results posted yet for this study

Summary

To evaluate the prevalence of Gastroesophageal reflux disease in Azerbaijan. It is intended to evaluate the prevalence of the disease in the regions as well as the capital by cluster sampling ,ethitology and to compare the outcomes depending on the geographical location.

Conditions

  • Gastroesophageal Reflux Disease

Sponsors & Collaborators

  • Azerbaijan Medical University

    collaborator OTHER

  • Sevda Aghayeva

    lead OTHER

Principal Investigators

  • Sevda Aghayeva, MD · Azerbaijan Gastroenterology and Hepatology Association

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-08-01
Completion
2019-09-01

Countries

  • Azerbaijan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03616119 on ClinicalTrials.gov